Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
Digestive Disease Week 2019.

P & T : a peer-reviewed journal for formulary management

Otrompke J.
PMID: 31258315
P T. 2019 Jul;44(7):428-429.

We review selected sessions on the questionable benefits of fecal microbiota transplant; intrahepatic cholestasis of pregnancy; weight-loss drugs in combination with intragastric balloon endoscopy; and beta blockers in pancreatic cancer.

Cite
Otrompke J. Digestive Disease Week 2019. P T. 2019;44(7):428-429
Otrompke, J. (2019). Digestive Disease Week 2019. P & T : a peer-reviewed journal for formulary management, 44(7), 428-429.
Otrompke, John. "Digestive Disease Week 2019." P & T : a peer-reviewed journal for formulary management vol. 44,7 (2019): 428-429.
Otrompke J. Digestive Disease Week 2019. P T. 2019 Jul;44(7):428-429. PMID: 31258315; PMCID: PMC6590930.
Copy Download .nbib Format: NLM
Seeking the value of pharmacogenetics in cardiovascular care.

Biotechnology healthcare

Otrompke J.
PMID: 23397416
Biotechnol Healthc. 2007 Feb;4(1):61-2.

Two presentations at the 2006 Scientific Sessions of the American Heart Association debated the effect of genetics on such drugs as warfarin and isosorbide dinitrate/hydralazine (BiDil). The speakers emphasized that the pharmacogenetics field is advancing quickly, but is not...

Cite
Otrompke J. Seeking the value of pharmacogenetics in cardiovascular care. Biotechnol Healthc. 2007;4(1):61-2
Otrompke, J. (2007). Seeking the value of pharmacogenetics in cardiovascular care. Biotechnology healthcare, 4(1), 61-2.
Otrompke, John. "Seeking the value of pharmacogenetics in cardiovascular care." Biotechnology healthcare vol. 4,1 (2007): 61-2.
Otrompke J. Seeking the value of pharmacogenetics in cardiovascular care. Biotechnol Healthc. 2007 Feb;4(1):61-2. PMID: 23397416; PMCID: PMC3564386.
Copy Download .nbib Format: NLM
Patent pending: biotech awaits answers on new trends.

Biotechnology healthcare

Otrompke JJ.
PMID: 23319936
Biotechnol Healthc. 2007 Aug;4(4):57-60.

How will today's biotech companies, large and small, weather the sea of change in intellectual property law? Most likely, the answer will vary from one company to the next - according to which side of the litigation it falls...

Cite
Otrompke JJ. Patent pending: biotech awaits answers on new trends. Biotechnol Healthc. 2007;4(4):57-60
Otrompke, J. J. (2007). Patent pending: biotech awaits answers on new trends. Biotechnology healthcare, 4(4), 57-60.
Otrompke, John J. "Patent pending: biotech awaits answers on new trends." Biotechnology healthcare vol. 4,4 (2007): 57-60.
Otrompke JJ. Patent pending: biotech awaits answers on new trends. Biotechnol Healthc. 2007 Aug;4(4):57-60. PMID: 23319936; PMCID: PMC3541845.
Copy Download .nbib Format: NLM
7th annual European congress of rheumatology.

Biotechnology healthcare

Otrompke J.
PMID: 23424375
Biotechnol Healthc. 2006 Aug;3(4):65-6.

No abstract available.

Cite
Otrompke J. 7th annual European congress of rheumatology. Biotechnol Healthc. 2006;3(4):65-6
Otrompke, J. (2006). 7th annual European congress of rheumatology. Biotechnology healthcare, 3(4), 65-6.
Otrompke, John. "7th annual European congress of rheumatology." Biotechnology healthcare vol. 3,4 (2006): 65-6.
Otrompke J. 7th annual European congress of rheumatology. Biotechnol Healthc. 2006 Aug;3(4):65-6. PMID: 23424375; PMCID: PMC3571082.
Copy Download .nbib Format: NLM
Variety of Biotech Therapies, Uses Take Prominence Among ASCO Presentations.

Biotechnology healthcare

Otrompke J.
PMID: 23424386
Biotechnol Healthc. 2006 Oct;3(5):55-8.

Presentations included treatments of various cancers, advances in stem cell therapy, and how gene variations affect drug action.

Cite
Otrompke J. Variety of Biotech Therapies, Uses Take Prominence Among ASCO Presentations. Biotechnol Healthc. 2006;3(5):55-8
Otrompke, J. (2006). Variety of Biotech Therapies, Uses Take Prominence Among ASCO Presentations. Biotechnology healthcare, 3(5), 55-8.
Otrompke, John. "Variety of Biotech Therapies, Uses Take Prominence Among ASCO Presentations." Biotechnology healthcare vol. 3,5 (2006): 55-8.
Otrompke J. Variety of Biotech Therapies, Uses Take Prominence Among ASCO Presentations. Biotechnol Healthc. 2006 Oct;3(5):55-8. PMID: 23424386; PMCID: PMC3571048.
Copy Download .nbib Format: NLM
Protocol for Efficient CRISPR/Cas9/AAV-Mediated Homologous Recombination in Mouse Hematopoietic Stem and Progenitor Cells.

STAR protocols

Tran NT, Trombke J, Rajewsky K, Chu VT.
PMID: 32685932
STAR Protoc. 2020 Jun 19;1(1):100028. doi: 10.1016/j.xpro.2020.100028.

Mutations that accumulate in self-renewing hematopoietic stem and progenitor cells (HSPCs) can cause severe blood disorders. To model such disorders in mice, we developed a CRISPR/Cas9/adeno-associated virus (AAV)-based system to knock in and repair genes by homologous recombination in...

Cite
Tran NT, Trombke J, Rajewsky K, et al. Protocol for Efficient CRISPR/Cas9/AAV-Mediated Homologous Recombination in Mouse Hematopoietic Stem and Progenitor Cells. STAR Protoc. 2020;1(1):100028doi: 10.1016/j.xpro.2020.100028.
Tran, N. T., Trombke, J., Rajewsky, K., & Chu, V. T. (2020). Protocol for Efficient CRISPR/Cas9/AAV-Mediated Homologous Recombination in Mouse Hematopoietic Stem and Progenitor Cells. STAR protocols, 1(1), 100028. https://doi.org/10.1016/j.xpro.2020.100028
Tran, Ngoc Tung, et al. "Protocol for Efficient CRISPR/Cas9/AAV-Mediated Homologous Recombination in Mouse Hematopoietic Stem and Progenitor Cells." STAR protocols vol. 1,1 (2020): 100028. doi: https://doi.org/10.1016/j.xpro.2020.100028
Tran NT, Trombke J, Rajewsky K, Chu VT. Protocol for Efficient CRISPR/Cas9/AAV-Mediated Homologous Recombination in Mouse Hematopoietic Stem and Progenitor Cells. STAR Protoc. 2020 Jun 19;1(1):100028. doi: 10.1016/j.xpro.2020.100028. PMID: 32685932; PMCID: PMC7357675.
Copy Download .nbib Format: NLM
Traveling a long and winding road toward personalized medicine.

Biotechnology healthcare

Otrompke J.
PMID: 23424374
Biotechnol Healthc. 2006 Aug;3(4):60-4.

To a third-party payer, perhaps the most interesting activity at this year's Biotechnology Industry Organization convention was not the din from the array of manufacturers and the states and countries hoping to land their business, but the sessions that...

Cite
Otrompke J. Traveling a long and winding road toward personalized medicine. Biotechnol Healthc. 2006;3(4):60-4
Otrompke, J. (2006). Traveling a long and winding road toward personalized medicine. Biotechnology healthcare, 3(4), 60-4.
Otrompke, John. "Traveling a long and winding road toward personalized medicine." Biotechnology healthcare vol. 3,4 (2006): 60-4.
Otrompke J. Traveling a long and winding road toward personalized medicine. Biotechnol Healthc. 2006 Aug;3(4):60-4. PMID: 23424374; PMCID: PMC3571075.
Copy Download .nbib Format: NLM
Billions of dollars for research at stake in health-reform case.

Nature medicine

Otrompke J.
PMID: 22561806
Nat Med. 2012 May 04;18(5):637. doi: 10.1038/nm0512-637.

No abstract available.

Cite
Otrompke J. Billions of dollars for research at stake in health-reform case. Nat Med. 2012;18(5):637doi: 10.1038/nm0512-637.
Otrompke, J. (2012). Billions of dollars for research at stake in health-reform case. Nature medicine, 18(5), 637. https://doi.org/10.1038/nm0512-637
Otrompke, John. "Billions of dollars for research at stake in health-reform case." Nature medicine vol. 18,5 (2012): 637. doi: https://doi.org/10.1038/nm0512-637
Otrompke J. Billions of dollars for research at stake in health-reform case. Nat Med. 2012 May 04;18(5):637. doi: 10.1038/nm0512-637. PMID: 22561806.
Copy Download .nbib Format: NLM
"It Starts With One": Reflections on BIO 2019.

P & T : a peer-reviewed journal for formulary management

Otrompke J.
PMID: 31447538
P T. 2019 Aug;44(8):491-493.

No abstract available.

Cite
Otrompke J. "It Starts With One": Reflections on BIO 2019. P T. 2019;44(8):491-493
Otrompke, J. (2019). "It Starts With One": Reflections on BIO 2019. P & T : a peer-reviewed journal for formulary management, 44(8), 491-493.
Otrompke, John. ""It Starts With One": Reflections on BIO 2019." P & T : a peer-reviewed journal for formulary management vol. 44,8 (2019): 491-493.
Otrompke J. "It Starts With One": Reflections on BIO 2019. P T. 2019 Aug;44(8):491-493. PMID: 31447538; PMCID: PMC6679953.
Copy Download .nbib Format: NLM
Showing 1 to 9 of 9 entries